Freestone Capital Holdings’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,018
| Closed | -$371K | – | 448 |
|
|
2021
Q2 | $371K | Sell |
2,018
-626
| -24% | -$115K | 0.02% | 308 |
|
|
2021
Q1 | $404K | Sell |
2,644
-7,916
| -75% | -$1.21M | 0.02% | 291 |
|
|
2020
Q4 | $1.65M | Buy |
10,560
+57
| +0.5% | +$8.91K | 0.1% | 170 |
|
|
2020
Q3 | $1.2M | Sell |
10,503
-274
| -3% | -$31.4K | 0.08% | 178 |
|
|
2020
Q2 | $1.21K | Buy |
10,777
+492
| +5% | +$55 | 0.01% | 186 |
|
|
2020
Q1 | $923 | Buy |
10,285
+1,257
| +14% | +$113 | 0.02% | 198 |
|
|
2019
Q4 | $976 | Sell |
9,028
-325
| -3% | -$35 | 0.02% | 264 |
|
|
2019
Q3 | $916 | Buy |
9,353
+494
| +6% | +$48 | 0.02% | 268 |
|
|
2019
Q2 | $1.16K | Buy |
8,859
+725
| +9% | +$95 | 0.03% | 223 |
|
|
2019
Q1 | $1.1M | Buy |
8,134
+3,776
| +87% | +$511K | 0.07% | 205 |
|
|
2018
Q4 | $424K | Buy |
4,358
+2,402
| +123% | +$234K | 0.03% | 310 |
|
|
2018
Q3 | $272K | Buy |
+1,956
| New | +$272K | ﹤0.01% | 328 |
|